The board of Charles River Laboratories has completed a strategic review of the company, deciding to cut costs and shift investments into animal testing alternatives and other potential areas of growth.
<a href="https://www.fiercebiotech.com/cro/charles-river-announces-cost-cutting-and-strategic-shift-revenue-slide-continues" hreflang="en">Charles River to cuts costs, shift direction as revenue slide continues</a>
FierceBiotech | | Darren Incorvaia
Topics: research